European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption.
Liese BarbierSteven R A SimoensArnold G VultoIsabelle HuysPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
This study argues in favour of a structural, multi-stakeholder framework at both European and national level to improve stakeholder biosimilar understanding and acceptance. It proposes a number of actionable recommendations that can inform policy making and guide stakeholders, which can contribute to realizing healthcare system benefits offered by biosimilar competition.